SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifescience India acquires stake in Mahi Drugs

13 Aug 2018 Evaluate

SMS Lifescience India has acquired 28,15,100 equity shares of Rs 10 each (59.70%) in Mahi Drugs on August 02, 2018. With this, the total stake of the company as on date in Mahi Drugs amounts to 78.79%.

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

Haleos Labs Share Price

1339.95 39.95 (3.07%)
20-Apr-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1233.20
Cipla 1231.45
Zydus Lifesciences 937.70
Lupin 2329.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×